In supplement marketing compliance hiring, claims literacy belongs in the screen, before the offer. A marketer who doesn't know where the line sits will write copy that crosses it. The brand carries that cost. The writer doesn't.
Marketing still doesn't own compliance. Approval sits with regulatory and legal, or with the CEO at smaller brands, and on a well-run supplement brand it stays out of marketing's hands. What the marketing hire controls is how much rework and risk lands on that approval step, whoever sits there.
Below is what the FTC and FDA each govern, what claims literacy looks like on a resume, and how to test for it in an interview. It's hiring guidance, not legal advice. Have qualified counsel or a regulatory professional review any specific claim.
A marketer without claims literacy generates volume that regulatory then rejects, which slows both teams down. Most supplement advertising compliance failures start at the brief. Review is just where they get caught.
The effect compounds in performance marketing, which runs on testing new angles every week. A strategist whose angles clear review on the first pass is worth more than one whose copy keeps coming back marked up.
Ownership stays where it belongs. At the supplement brands we recruit for, DSHEA and GMP compliance sit with product and regulatory operators. Marketing hires are screened for fluency, so fewer problems reach the people who own the decision.
These two get blurred constantly, including by candidates who claim compliance experience.
The FTC published its Health Products Compliance Guidance in December 2022, replacing the 1998 dietary supplement advertising guide that many older marketing articles still cite. It applies to health-related product advertising broadly, and it defines competent and reliable scientific evidence as research conducted and evaluated objectively by qualified people, using procedures generally accepted in the field to yield accurate and reliable results. In practice the guidance points to randomized controlled human clinical testing as the general expectation for health benefit claims.
A candidate who treats the FTC and FDA as one regulator hasn't worked closely with either.
Structure/function is the FDA's term. Use it the way the agency does.
The FDA defines a structure/function claim as a statement describing the role of a nutrient or dietary ingredient in affecting the structure or function of the human body. Under the Federal Food, Drug, and Cosmetic Act, these claims can appear on supplement labeling if three conditions hold. The brand holds substantiation that the statement is truthful and not misleading. The statement doesn't claim to diagnose, mitigate, treat, cure or prevent a disease. And the standard disclaimer appears prominently in boldface: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."
In December 2025, the FDA said it would stop enforcing the rule that the disclaimer repeat on every label panel carrying a claim, while it considers amending the regulation. The disclaimer itself, and its link to each claim, still apply.
Two points matter for marketing. The FDA doesn't pre-approve these claims, so nobody has signed off in advance. The brand must also notify the FDA with the text of the claim no later than 30 days after first marketing the supplement with it. Filing that notification doesn't mean the FDA approved anything.
Exposure concentrates in the places brands review least.
User-generated content is the clearest example. A creator saying something on camera that the brand would never write is still the brand's advertising once it runs as an ad. Testimonials, before-and-after framing and implied outcomes carry the same weight as body copy.
Ad headlines and hooks are the second concentration. The shorter the format, the more compression, and compression is where a permissible statement turns into an implied disease claim.
Landing pages are the third, particularly when the page carries claims the label does not. The FTC's guidance covers health-related advertising, not just labels, so a compliant label doesn't settle what an ad can say. Some pages count as both advertising and labeling, which puts them in scope for both agencies.
Look for evidence of process. Claimed familiarity tells you nothing.
On a resume, experience inside a compliant system shows up as a named review workflow: who approved copy and how long approval took. The strongest signal is ownership of an approved claims bank. An approved claims bank is a pre-cleared library of claim language, each line tied to its substantiation, that helps supplement marketers produce new creative without sending every variation back through review.
Category adjacency matters too. Candidates from nutraceutical marketing roles at ingredient or manufacturing brands answer to the same regulators, so they're the closest match. Other regulated consumer categories, such as OTC drugs, alcohol or cosmetics, transfer well too, because writing to an approved claim set is the same discipline under a different regulator.
Missing all of this isn't disqualifying at junior levels. For a lead strategist or head of marketing, it usually is.
Four questions separate genuine experience from vocabulary.
Ask the candidate to explain what the FTC regulates versus what the FDA regulates, and where the two overlap. Vague answers are common and informative. Strong candidates know the agencies split jurisdiction but share a substantiation standard.
Ask them to take a strong marketing claim and rewrite it so it would survive review, then explain what they changed and why. This is the closest thing to a work sample for this skill. A strong answer reaches for structure/function framing and the required disclaimer. A weak one just softens an adjective.
Ask what happened the last time a creator said something in an ad that shouldn't have run, and what changed afterward. Then ask who approved their copy in their last role and how long approval took. A candidate who can't describe the workflow probably wasn't inside one.
Meta, Google and TikTok enforce their own ad policies independently of either regulator, and those policies change often.
A lawful claim can still get rejected, and a platform can restrict an account over a pattern of ads, not just one.
Ask candidates whether they have had a supplement ad account restricted and what they did to recover it. Operators who've been through that once behave differently afterward, usually for the better.
At smaller supplement brands, the CEO usually works through claims review personally and is always the one signing the documents. As the brand grows, regulatory and legal take over the review, but the need to understand it never goes away. Marketing, sales, communications and performance hires all write claims in some form, so review literacy belongs in the screen for every one of them, at every stage.
Claims risk in supplement brands is usually a systems problem presenting as a copy problem. A supplement brand marketing hire who writes to an approved claim set keeps volume high and rework low. At a small brand, every miss lands on the CEO's desk. Getting it wrong means slow marketing or exposed marketing, and both are expensive.
Constant Hire's supplement brand recruiters have made 30+ supplement brand placements. We present first interviews within 5 business days, and mid-level operators typically place in 4–6 weeks. We also recruit for food brands and CPG brands, where FDA labeling rules shape the same marketing hires.
No. Structure/function claims are not pre-approved by the agency. The brand must hold substantiation that the statement is truthful and not misleading, display the standard disclaimer prominently, avoid any disease claim, and notify the FDA with the text of the claim within 30 days of first marketing the product with it. The notification isn't an approval.
No. Approval belongs with regulatory and legal, or with the CEO at smaller brands. What marketing needs is literacy, so that copy arrives at review already close to compliant. Treating marketing as the owner of compliance creates risk, and treating it as exempt from understanding creates rework.
Often yes. The discipline of writing to an approved claim set transfers well even when the regulator differs, which makes candidates from other regulated consumer categories worth considering. Verify their understanding of the FTC and FDA split specifically, since that part does not transfer automatically.
Top talent on your calendar in under 5 days.
